{"id":"W2016829028","doi":"10.1111/apt.12911","title":"Editorial: drug monitoring targets for optimising adalimumab in Crohn's disease","year":2014,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Prometheus","keywords":"Adalimumab; Medicine; Infliximab; Internal medicine; Crohn's disease; Gastroenterology; Therapeutic drug monitoring; Disease; Population; Drug; Antibody; Immunology; Pharmacology; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005793371,0.005764468,0.005285278,0.003123341,0.002450133,0.005883715,0.005708356,0.02125218,0.01670911],"category_scores_gemma":[0.01830951,0.001745861,0.004066531,0.001439558,0.002899708,0.006095921,0.001123245,0.02429889,0.01589152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002928774,"about_ca_system_score_gemma":0.001861491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001079461,"about_ca_topic_score_gemma":0.001712956,"domain_scores_codex":[0.9954894,0.0007222515,0.0005986257,0.000696114,0.002099548,0.0003940711],"domain_scores_gemma":[0.9818411,0.007905534,0.001133863,0.0005958959,0.005911365,0.002612288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002659532,0.00005998691,0.00007695285,0.0004940298,0.00005084255,0.0002833031,0.00001433641,0.00009431417,0.0001496395,0.0004490516,0.9896021,0.00845939],"study_design_scores_gemma":[0.0004064681,0.0002528689,0.0009990424,0.000767878,0.0001490729,0.0009093067,0.00005245757,0.0007163545,0.0004316637,0.001712412,0.9935428,0.00005966104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0001369276,0.003728728,0.0002628346,0.02497783,0.9687524,0.0000515202,0.0001271258,0.0001909591,0.001771683],"genre_scores_gemma":[0.0006004804,0.00224809,0.000140136,0.01662797,0.9764776,0.00001970124,0.00004781065,0.00003928445,0.003798846],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.02125218,"threshold_uncertainty_score":0.05589759,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01069339877278326,"score_gpt":0.307854837642376,"score_spread":0.2971614388695927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}